Christine A. Nash, SVP & Chief Commercial Officer at HYPERION THERAPEUTICS INC (HPTX), sold 10,000 shares at $37.56 ($376K) on 2015-03-17, disclosed to the SEC on 2015-03-17.
Scheduled sale ($376k) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HPTX | SELL | 2015-01-22 | $124K | — | Filing → |
| HPTX | SELL | 2014-03-10 | $148K | — | Filing → |
| HPTX | SELL | 2014-01-14 | $241K | — | Filing → |